• 1
    Zuberbier T., Chantraine-Hess S., Hartmann K., Czarnetzki B M.. Pseudoallergen-free diet in the treatment of chronic urticaria. Acta Derm Venereol (Stockh) 1995: 75: 484487.
  • 2
    Natbony S F., Phillips M E., Elias J M., Godfrey H P., Kaplan A P.. Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin Immunol 1986: 78: 914918.
  • 3
    Haas N., Toppe E., Henz B M.. Microscopic morphology in different types of urticaria. Arch Dermatol 1998: 134: 4146.
  • 4
    Toppe E., Haas N., Henz B M.. Neutrophilic urticaria – clinical features, histological changes and possible mechanisms. Br J Dermatol 1998: 138: 248253.
  • 5
    Henz B M., Zuberbier T., Grabbe J., Monroe E. Urticaria – clinical, diagnostic and therapeutic approaches. Berlin : Springer, 1998.
  • 6
    Patel P., Gasbarrini G., Pretolani S., Gasbarrini A., Franceschi F. Extradigestive diseases and Helicobacter pylori infection. Curr Opin Gastroenterol 1997: 13: 5255.
  • 7
    Hartmann K., Henz B M., Krüger-Krasagakes S. et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997: 89: 28632870.
  • 8
    Lippert U., Artuc M., Grützkau A. et al. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol, in press.
  • 9
    Kirshenbaum A S., Goff J P., Kessler S W., Mican J M., Zsebo K M., Detcalfe D D.. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J Immunol 1992: 148: 772777.
  • 10
    Nilsson G., Butterfield J H., Nilsson K., Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994: 153: 37173723.
  • 11
    Welker P., Grabbe J., Grützkau A., Henz B M.. Effect of NGF and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology, in press.
  • 12
    Lockey S D.. Allergic reactions due to FD and C yellow No. 5, tartrazine, aniline dye used as colouring and identifying agent in various steroids. Ann Allergy 1959: 17: 719721.
  • 13
    Juhlin L., Michaelsson G., Zetterström O. Urticaria and asthma induced by food and drug additives in patients with aspirin hypersensitivity. J Allergy Clin Immunol 1972: 50: 9298.
  • 14
    Schlumberger H D.. Pseudoallergic reactions to drugs and chemicals. Ann Allergy 1983: 51: 317458.
  • 15
    Haustein U-F. Pseudoallergen-free diet in the treatment of chronic urticaria. Acta Derm Venereol (Stockh) 1976: 76: 498499.
  • 16
    Zuberbier T., Ehlers I., Pfrommer C., Vieths S., Henz B M.. Aromastoffe-Bisher unbekannte Auslöser von Nahrungs-mittelpseudoallergien bei chronischer Urtikaria. In: C.Garbe, G.Rassner (Hrsg.) Dermatologie. Leitlinien und Qualitätssicherung für Diagnostik und Therapie. Berichte von der 39. Tagung der Deutschen Dermatologischen Gesellschaft. Heidelberg : Springer, 1998: 124126.
  • 17
    Pfrommer C., Bastl R., Vieths S., Ehlers I., Henz B M., Zuberbier T. Characterization of naturally occurring pseudoallergens causing chronic urticaria. J Allergy Clin Immunol 1996: 97: 367.
  • 18
    Greaves M W., O'Donnell B F.. Not all chronic urticaria is “idiopathic” Exp Dermatol 1998: 7: 1113.
  • 19
    Grattan C E H., Boon A P., Eady R A J., Winkelmann R K.. The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions. Int Arch Allergy Appl Immunol 1990: 93: 198204.
  • 20
    Grattan C E., Francis D M., Hide M., Greaves W M.. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 1991: 21: 221224.
  • 21
    Hide M., Francis D M., Grattan C E., Hakimi J., Kochan J P., Greaves M W.. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993: 328: 15991604.
  • 22
    Niimi N., Francis DM, Kermani F. et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996: 106: 10011006.
  • 23
    Hide M., Francis D M., Grattan C E., Barr R M., Winkelmann R K., Greaves M W.. The pathogenesis of chronic idiopathic urticaria: new evidence suggests an autoimmune basis and implications for treatment. Clin Exp Allergy 1994: 24: 624627.
  • 24
    Fiebiger E., Maurer D., Holub H. et al. Serum IgG autoantibodies directed against the α chain of Fc-RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients J Clin Invest 1995: 96: 26062612.
  • 25
    Fiebiger E., Hammerschmidt F., Stingl G., Maurer D. Anti-Fc-RI autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 1998: 101: 243251.
  • 26
    Tong L J., Balakrishnan G., Kochan J P., Kinet J-P., Kaplan A P.. Assessment of autoimmunity inpatients with chronic urticaria. J Allergy Clin Immunol 1997: 99: 461465.
  • 27
    Grattan C E H., Francis D M., Slater N G P., Barlow R J., Greaves M W.. Plasmapheresis for severe unremitting chronic urticaria. Lancet 1992: 339: 10781080.
  • 28
    Barlow R J., Black A K., Greaves M W.. Treatment of severe chronic urticaria with cyclosporin A. Eur J Dermatol 1993: 3: 273275.
  • 29
    Fradin M S., Ellis C N., Goldfarb M T., Voorhees J J.. Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol 1991: 25: 10651067.